Delivery Order SPE2DB22D1200-SPE2DB25FN3KR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,682.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in a 100 ml pack. The contract was competitively awarded without set-aside designation under firm fixed pricing and is scheduled for completion by September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,365.00 delivery order to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs, with an ultimate completion date of September 5, 2025. This is a firm fixed price, non-set-aside delivery order sourced from AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the company's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,523.75 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs on September 12, 2025, with an ultimate completion date of October 3, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for Epidiolex 100 mg/ml solution in 100 ml packs, valued at $10,095.00 under a firm fixed price arrangement. The delivery order, which is non-set-aside and competitively awarded, has an ultimate completion date of May 15, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,412.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs, with an ultimate completion date of September 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the vendor's facility in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,412.50 on August 29, 2025, for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 22, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,280.92 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, with an ultimate completion date of October 6, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved cannabidiol medication used primarily for...
- The Defense Logistics Agency awarded a delivery order valued at $3,365.00 to AmerisourceBergen Drug Corp for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. This firm fixed-price delivery order, awarded on August 29, 2025, is scheduled for completion by September 22, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a non-set-aside competitive award, demonstrating the vendor's capability to meet federal...
- The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, valued at $1,280.92 with a firm fixed price contract type. The award was not set aside for small businesses or other designated groups and carries an ultimate completion date of September 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Epidiolex 100 mg/ml solution in 100 ml packs, with a ceiling value of $1,481.70 and an ultimate completion date of October 7, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and represents a continuation of AmerisourceBergen's pharmaceutical supply relationship with the federal government. The place of performance is located...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB25FN3KRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,682.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packaging, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside transaction and leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical deliveries through the DLA Medical Supply Chain, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Epidiolex, an FDA-approved anti-seizure medication, reflects the company's capability to fulfill specialized pharmaceutical requirements for Department of Defense healthcare programs through established contract vehicles that enable rapid procurement of critical medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/28/25 |